tirzepatide and rheumatoid arthritis for Zepbound (Tirzepatide): A Q&A on the Mounjaro-Like Weight Loss Drug GLP-1 Receptor Agonists May Improve
Description
This patient deals with type 2 diabetes and, later on, used Ozempic to achieve lowered A1C under 7% while losing some weight throughout the process
Contraindications include personal or family history of medullary thyroid cancer and multiple endocrine neoplasia type 2 syndrome
Avoid injecting within two hours of a large meal
GLP-1 receptor agonists, a class within the incretins, cause varying degrees of weight loss among patients
